RHÖN-KLINIKUM Aktiengesellschaft (XTRA: RHK)
Health Care · Health Care Providers & Services · DE
€14.40
0.00% today · +23.1% 1Y
RHÖN-KLINIKUM Aktiengesellschaft (XTRA: RHK) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.08B and employs 19,120 people.
Over the last twelve months the share price has gained 23.1%, trading between 11.30 and 15.70.
Tweenvest scores RHÖN-KLINIKUM Aktiengesellschaft across four factors: quality 76/100, value 66/100, growth 28/100, dividend 32/100. Its strongest factor is quality.
RHK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.08B
- Revenue (TTM)
- $2.32B
- P/E
- 22.90
- EPS
- 0.63
- Dividend yield
- 1.39%
- Beta (5Y)
- -0.00
- 52-week high
- €15.70
- 52-week low
- €11.30
- Avg volume (3M)
- —
- Shares outstanding
- 66.94M
- Employees
- 19,120
- Next earnings
- —
About RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.
- ISIN
- DE0007042301
- Founded
- 1973
- Listed since
- Nov 25, 1998
- Exchange
- XETRA Trading Platform
- Currency
- EUR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AS ONE CorporationTSE: 7476 | $1.12B | ¥2,495.00 | +1.61% |
| Uniphar plcISE: UPR | $1.12B | €3.89 | +1.30% |
| Innovative Medical Management Co.,Ltd.SZSE: 002173 | $1.10B | CN¥16.77 | -2.84% |
| New Journey Health Technology Group Co.,LTDSZSE: 002219 | $1.08B | CN¥2.11 | +0.48% |
| Akso Health GroupNasdaqCM: AHG | $1.07B | $1.25 | +8.70% |
| Life Healthcare Group Holdings LimitedJSE: LHC | $1.05B | R12.18 | +4.73% |
| Castle Biosciences, Inc.NasdaqGM: CSTL | $1.05B | $34.42 | -3.21% |
| CVS Group plcLSE: CVSG | $1.05B | £11.71 | -0.17% |
Figures last refreshed Oct 11, 2026.